Aptamer-guided method maps transcription factor binding sites quickly, suggesting advances in gene regulation studies.
Mapping transcription factor (TF) binding sites is crucial for understanding the regulatory mechanisms by which TFs and associated proteins control biological processes. Existing methods rely on antibodies as protein-binding reagents, making them highly dependent on the availability and quality of commercial antibodies. Here, we present Aptamer-Guided Chromatin Cleavage with Sequencing (AptaChC-seq), an antibody-free approach for rapid profiling of TF binding sites that leverages aptamer-directed Tn5 transposome tagmentation. We demonstrate the efficacy of AptaChC-seq through successful application to three TFs, including FOXM1, RELA, and RBPJ, yielding high-quality mapping data. Our results show that aptamers exhibit high stability and reproducibility in this context. Furthermore, the AptaChC-seq workflow can be completed in approximately 4 h, making it the fastest currently available method for TF binding site profiling. This approach provides a robust complementary tool for TF studies, facilitating mechanistic investigations and advancing biomedical applications.
No takes yet. Share an insight, caveat, or question.
Teng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: